Last reviewed · How we verify

NCT06913972

A Comparative Analysis of Myopia Prevalence Among Madarsa Students vs. Non-Madarsa Students in Sukkur

Active, enrolled Last updated 6 April 2025
What this trial tests

trial in Myopia in 364 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
20 March 2025
Primary endpoint
20 June 2025
20 February 2026

Quick facts

Lead sponsorSuperior University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment364
Start date20 March 2025
Primary completion20 June 2025
Estimated completion20 February 2026
Sites1 location across Pakistan

Conditions studied

Sponsor

Superior University

Who can join

Adults 5 to 20, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Myopia (nearsightedness) has become a major global health concern, particularly among students, due to factors such as prolonged screen time, close-up work, and limited outdoor activities. In regions like Sukkur, Pakistan, the educational environments and lifestyles of students in Madarsas (religious schools) differ significantly from those in non-Madarsa (regular) schools, potentially influencing the prevalence of myopia. This comparative cross-sectional study aims to assess and compare the prevalence of myopia among Madarsa and non-Madarsa students in Sukkur.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06913972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing